Here is news about Orofacial Therapeutics, one of the founding partners of FaceMyPain.com. Orofacial Therapeutics was named a Top 10 Pain Solution Provider by MedTech Outlook, a magazine for the medical industry that focuses on new ways of tackling healthcare challenges. Orofacial Therapeutics was selected for addressing facial pain in a manner that is low cost, scalable, and establishes a new model for delivering standardized care for acute musculoskeletal pain conditions of the head and/or neck.
The most common cause of facial pain is a group of conditions called temporomandibular joint and muscle disorders (TMJDs). TMJDs are the second most commonly occurring musculoskeletal conditions resulting in pain and disability (after chronic low back pain), affecting approximately 5 to 12% of the population, with an annual cost estimated at $4 billion. Dentists have reported increases in the prevalence of TMJ symptoms, bruxism, and chipped and cracked teeth among their patients since the COVID-19 pandemic began.
Read the news in its entirety here: Link to news